Literature DB >> 2044228

Bacterial antibodies in ankylosing spondylitis.

O Mäki-Ikola1, K Lehtinen, K Granfors, R Vainionpää, P Toivanen.   

Abstract

Antibodies to Salmonellae, Yersiniae, Campylobacter jejuni, Borrelia burgdorferi, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis and Chlamydia trachomatis were measured by ELISA in the sera of 99 patients with ankylosing spondylitis. Increased prevalence of IgA and IgG class antibodies against K. pneumoniae and of IgA class against E. coli was observed in ankylosing spondylitis. No clear correlation between the disease activity and occurrence of antibodies was revealed. The results are in line with the previously published findings suggesting that K. pneumoniae may have a role in the aetiopathogenesis of ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044228      PMCID: PMC1535427     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

2.  Enzyme-linked immunosorbent assay for immunoglobulin G and M antibodies to Chlamydia trachomatis in human sera.

Authors:  M P Finn; A Ohlin; J Schachter
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

3.  Antibodies to proteus in rheumatoid arthritis.

Authors:  A Ebringer; T Ptaszynska; M Corbett; C Wilson; Y Macafee; H Avakian; P Baron; D C James
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

4.  Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

5.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

6.  Spondyloarthritis, uveitis, HLA-B27 and Klebsiella.

Authors:  A Ebringer; M Baines; T Ptaszynska
Journal:  Immunol Rev       Date:  1985-08       Impact factor: 12.988

7.  HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.

Authors:  A Trull; A Ebringer; G Panayi; R Ebringer; D C James
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

8.  Combined use of released proteins and lipopolysaccharide in enzyme-linked immunosorbent assay for serologic screening of Yersinia infections.

Authors:  O Mäki-Ikola; J Heesemann; R Lahesmaa; A Toivanen; K Granfors
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

9.  Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients.

Authors:  T U Kosunen; H Rautelin; T Pitkänen; A Pönkä; T Pettersson
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

10.  IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; R Ebringer; G S Panayi; D Colthorpe; D C James; A Ebringer
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

View more
  18 in total

1.  The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

Review 2.  Stress proteins in the pathogenesis of spondyloarthritis.

Authors:  José Pablo Romero-López; María Lilia Domínguez-López; Rubén Burgos-Vargas; Ethel García-Latorre
Journal:  Rheumatol Int       Date:  2018-05-31       Impact factor: 2.631

3.  Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens.

Authors:  J M Brand; P Neustock; A Kruse; L Alvarez-Ossorio; A Schnabel; H Kirchner
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

4.  Ig A antibodies to klebsiella in ankylosing spondylitis.

Authors:  O Ardiçoğlu; M B Atay; H Ataoğlu; N Etiz; H Ozenci
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

5.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

6.  Ankylosing spondylitis in monozygotic twins: studies on immunological parameters.

Authors:  T Höhler; R Hug; P M Schneider; F Krummenauer; C Gripenberg-Lerche; K Granfors; E Märker-Hermann
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

7.  IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis.

Authors:  S H Sprenkels; E Van Kregten; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 8.  Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy.

Authors:  A Ebringer; K Ahmadi; M Fielder; T Rashid; H Tiwana; C Wilson; A Collado; Y Tani
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

9.  IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis.

Authors:  S H Sprenkels; J Uksila; R Vainionpää; P Toivanen; T E Feltkamp
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

10.  Incidence of Yersinia enterocolitica antibodies in patients with inflammatory joint diseases.

Authors:  V Tamburrino; R Monno; M A Valenza; R Numo
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.